COMP <GO>
BSEM vs JNJ // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
BioStem Technologies Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: BSEM 1
— JNJ 8
■ METRIC PARITY
LAST: $1.29 (-14.57%) • MKT CAP: $24.1M
options-implied-move
—
LAST: $275.20 (+1.54%) • MKT CAP: $662.49B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BSEM VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BSEM | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 93.60% | 67.90% | +25.70 | BSEM | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -5.70% | 25.50% | -31.20 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 18.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 2.97% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -1.50% | 34.70% | -36.20 | JNJ | /operating-margins <GO> |
| Net Profit Margin | -13.90% | 28.50% | -42.40 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | -31.80% | 6.00% | -37.80 | JNJ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.44 | 5.59 | -3.15 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 8/9 | -3.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 28.3 | 62.1 | -33.80 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 23.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $24.1M | $662.49B | -$662.47B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BSEM REV | JNJ REV | BSEM GROSS % | JNJ GROSS % | BSEM FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $47.5M | $94.19B | 93.6% | 67.9% | $6.6M | $19.70B |
| FY 2024 | $69.7M | $88.82B | 80.3% | 69.1% | $24.0M | $19.84B |
| FY 2023 | — | $85.16B | — | — | — | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BSEM // BETA —
JNJ // BETA 1.08